BR220665 - HEMANEXT ONE
De Novo Number: BR220665
Applicant: Hemanext, Inc.
Device Name: HEMANEXT ONE
Decision Date: 9/15/2023
On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.
De Novo Number: BR220665
Applicant: Hemanext, Inc.
Device Name: HEMANEXT ONE
Decision Date: 9/15/2023